Somatic mutations in TP53 are frequent in all human cancers, and in BCC, non-synonymous mutations occur sporadically in approximately 61% of cases [7,52], with hotspots identified at codons 177, 196 and 245 [56,57]. This evidence concerns the gene TP53 and skin basal cell carcinoma.